Skip to main content

Marotta Asset Management

Position in NVO — Novo Nordisk A S

CIK 1802091 CHARLOTTESVILLE, VA

Position in NVO

as of Jun 30, 2026 · filed Jul 9, 2026
Position Value
$648,724
+$124,008 QoQ
Shares Held
13,532
-5.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.17%
of 13F equity value
Holder Rank
#635
of 1,348 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Marotta Asset Management holds $2,186,347 across 4 Drug Manufacturers - General names. NVO ranks #2 (29.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NVO
Novo Nordisk A S
This page
13,532 $648,724

All Filings in NVO

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $648,724 13,532
2026-03-31 $524,716 14,278
2025-12-31 $727,431 14,297
2025-09-30 $806,325 14,531
2025-06-30 $1,010,521 14,641
2025-03-31 $1,156,384 16,653
2024-12-31 $1,383,889 16,088
2024-09-30 $1,982,872 16,653
2024-06-30 $2,415,874 16,925
2024-03-31 $2,211,818 17,226
2023-12-31 $1,794,236 17,344
2023-09-30 $1,591,450 17,500
2023-06-30 $1,438,506 8,889
2022-12-31 $1,210,210 8,942
2022-09-30 $930,544 9,340
2022-06-30 $1,079,310 9,686
2022-03-31 $1,075,741 9,687
2021-12-31 $1,220,016 10,893
2021-09-30 $969,028 10,093
2021-06-30 $847,082 10,112
2021-03-31 $601,318 8,919